Beating earnings estimates typically leads to positive investor sentiment and can cause a short-term increase in stock price. The fact that Prime Medicine outperformed analyst expectations by a noticeable margin suggests a stronger financial health than anticipated, which could lead to increased investor confidence and a potential uplift in the stock's value.